Literature DB >> 33608157

Reply to Michael Froehner, Rainer Koch, and Markus Graefen's Letter to the Editor re: Nicolas Mottet, Roderick C.N. van den Bergh, Erik Briers, et al. EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent. Eur Urol 2021;79:243-62. Comorbidity Measurement in Patients with Prostate Cancer.

Roderick C N van den Bergh1, Shane O'Hanlon2, Philip Cornford3, Nicolas Mottet4.   

Abstract

Entities:  

Year:  2021        PMID： 33608157     DOI： 10.1016/j.eururo.2021.02.006

Source DB:  PubMed          Journal:  Eur Urol        ISSN： 0302-2838            Impact factor:   20.096


× No keyword cloud information.
  12 in total

1.  Mismatched Imaging Findings of Prostate Cancer Diagnosis: 68 Ga-PSMA PET/CT vs mpMRI.

Authors:  Egesta Lopci; Piergiuseppe Colombo; Massimo Lazzeri
Journal:  Nucl Med Mol Imaging       Date:  2021-06-02

2.  Dual-Functional PLGA Nanoparticles Co-Loaded with Indocyanine Green and Resiquimod for Prostate Cancer Treatment.

Authors:  Wenfeng Lin; Chaoming Li; Naijin Xu; Masami Watanabe; Ruizhi Xue; Abai Xu; Motoo Araki; Ruifen Sun; Chunxiao Liu; Yasutomo Nasu; Peng Huang
Journal:  Int J Nanomedicine       Date:  2021-04-12

3.  MRI features of the normal prostatic peripheral zone: the relationship between age and signal heterogeneity on T2WI, DWI, and DCE sequences.

Authors:  Vlad Bura; Iztok Caglic; Ziga Snoj; Nikita Sushentsev; Alexandra S Berghe; Andrew N Priest; Tristan Barrett
Journal:  Eur Radiol       Date:  2021-01-04       Impact factor: 5.315

4.  Salvage Radiotherapy for Macroscopic Local Recurrence Following Radical Prostatectomy.

Authors:  Hind Zaine; Benjamin Vandendorpe; Benoit Bataille; Thomas Lacornerie; Jennifer Wallet; Xavier Mirabel; Eric Lartigau; David Pasquier
Journal:  Front Oncol       Date:  2021-04-15       Impact factor: 6.244

5.  Rebiopsy rate after transperineal or transrectal prostate biopsy.

Authors:  Jose L Marenco Jimenez; Francesco Claps; Juan C Ramón-Borja; Juan M Mascarós Martinez; Augusto W Gutierrez; Álvaro G F Lozano; Miguel Ramírez-Backhaus; Jose L Domìnguez Escrig; Argimiro C Serra; Jose Rubio-Briones
Journal:  Prostate Int       Date:  2020-10-17

6.  Combining prostate health index and multiparametric magnetic resonance imaging in estimating the histological diameter of prostate cancer.

Authors:  Po-Fan Hsieh; Tzung-Ruei Li; Wei-Ching Lin; Han Chang; Chi-Ping Huang; Chao-Hsiang Chang; Chi-Rei Yang; Chin-Chung Yeh; Wen-Chin Huang; Hsi-Chin Wu
Journal:  BMC Urol       Date:  2021-11-20       Impact factor: 2.264

Review 7.  PROSTATE CANCER DIAGNOSIS IN 2019 - CHANGES IN EUROPEAN GUIDELINES AND IMPACT ON DAILY PRACTICE.

Authors:  Igor Tomašković; Sven Nikles; Miroslav Tomić; Ivan Pezelj; Boris Ružić
Journal:  Acta Clin Croat       Date:  2019-11       Impact factor: 0.780

Review 8.  Therapeutic metastatic prostate cancer vaccines: lessons learnt from urologic oncology.

Authors:  Witold Lasek; Łukasz Zapała
Journal:  Cent European J Urol       Date:  2021-06-11

9.  Use of 29-MHz Micro-ultrasound for Local Staging of Prostate Cancer in Patients Scheduled for Radical Prostatectomy: A Feasibility Study.

Authors:  Federica Regis; Paolo Casale; Francesco Persico; Piergiuseppe Colombo; Miriam Cieri; Giorgio Guazzoni; Nicolò Maria Buffi; Giovanni Lughezzani
Journal:  Eur Urol Open Sci       Date:  2020-06-17

10.  Mobile PSA: A Novel Telehealth Tool for Prostate Cancer Follow-Up.

Authors:  Robin Bergroth; Mika Matikainen; Antti Rannikko
Journal:  Eur Urol Open Sci       Date:  2021-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.